Page last updated: 2024-11-12
esculeoside a
Description
esculeoside A: a major component contained in the ripe tomato Lycopersicon esculentum fruits; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
esculeoside A : A steroid saponin that is spirosolane-3,23,27-triol in which the hydroxy group at position 23 is acetylated and the hydroxy groups at positions 3 and 27 are glycosylated by lycotetraosyl and a beta-D-glucopyranosyl moieties respectively. Isolated from the fruits of Lycopersicon esculentum, it exhibits cytotoxic activity. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (11)
Synonym |
esculeoside a |
CHEBI:65866 |
(23s,25s)-23-acetoxy-5alpha,22alphan-3beta,27-dihydroxyspirosolan-3-o-beta-lycotetraosyl-27-o-beta-d-glucopyranoside |
(3beta,5alpha,22alpha,23s,25s)-27-(beta-d-glucopyranosyloxy)-3-{[beta-d-glucopyranosyl-(1->2)-[beta-d-xylopyranosyl-(1->3)]-beta-d-glucopyranosyl-(1->4)-beta-d-galactopyranosyl]oxy}spirosolan-23-yl acetate |
532387-86-3 |
3-o-.beta.-lycotetraosyl (5s,22s,23s,25s)-23-acetoxy-3.beta.,27-dihydroxyspirosolane 27-o-.beta.-d-glucopyranoside |
(3.beta.,5.alpha.,22.alpha.,23s,25s)-23-(acetyloxy)-27-(.beta.-d-glucopyranosyloxy)spirosolan-3-yl o-.beta.-d-glucopyranosyl-(1->2)-o-(.beta.-d-xylopyranosyl-(1->3))-o-.beta.-d-glucopyranosyl-(1->4)-.beta.-d-galactopyranoside |
unii-g4ut79k5t5 |
(3beta,5alpha,22alpha,23s,25s)-23-(acetyloxy)-27-(beta-d-glucopyranosyloxy)spirosolan-3-yl o-beta-d-glucopyranosyl-(1->2)-o-(beta-d-xylopyranosyl-(1->3))-o-beta-d-glucopyranosyl-(1->4)-beta-d-galactopyranoside |
3-o-beta-lycotetraosyl (5s,22s,23s,25s)-23-acetoxy-3beta,27-dihydroxyspirosolane 27-o-beta-d-glucopyranoside |
g4ut79k5t5 , |
Research Excerpts
Treatment
Roles (2)
Role | Description |
metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
antineoplastic agent | A substance that inhibits or prevents the proliferation of neoplasms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (5)
Class | Description |
saponin | A glycoside that is a compound containing one or more hydrophilic glycoside moieties combined with a lipophilic triterpenoid or steroid derivative. Found in particular abundance in plant species. |
steroid alkaloid | |
azaspiro compound | An azaspiro compound is a spiro compound in which at least one of the cyclic components is a nitrogen heterocyle. |
oxaspiro compound | A spiro compound in which at least one of the cyclic components is an oxygen heterocyle. |
steroid saponin | Any saponin derived from a hydroxysteroid. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (13)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 22.61
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 22.61 (24.57) | Research Supply Index | 2.64 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 21.17 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (7.69%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (92.31%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |